Elevance Health Stock Plummets 5.26% with 19.76 Billion Shares Traded Ranking 65th in Market Activity

On April 4, 2025, Elevance Health (ELV) experienced a significant drop of 5.26%, with a trading volume of 19.76 billion, ranking 65th in the day's market activity.

Elevance Health's stock price fell to $435.81, marking a 3.73% decline from its previous close of $452.70. The stock reached an intraday low of $434.88 before slightly recovering. This price movement places ELV 23.17% below its 52-week high of $567.26 and 20.32% above its 52-week low of $362.21.

Analysts have set an average price target of $488.08 for Elevance Health, with estimates ranging from $405.00 to $625.00. This target suggests a potential upside of 11.99% from the current price. Additionally, the consensus recommendation from brokerage firms indicates an "Outperform" status, with an average rating of 2.1 on a scale where 1 signifies a Strong Buy and 5 denotes a Sell.

GuruFocus estimates the GF Value for Elevance Health to be $621.89 in one year, implying a 42.7% upside from the current price. This estimate is based on historical trading multiples, past business growth, and future performance projections. However, it is important to note that this analysis does not consider the most recent company announcements or qualitative information.